Stratification of patients with COPD according to the 2011 GOLD report;Stratyfikacja pacjentów z POChP według raportu GOLD 2011

Pneumonologia i Alergologia Polska

Volumn 82, Issue 5, 2014, Pages 415-421

  Grzelewska Rzymowska, Iwona ^a   Patora Mikołajczyk, Joanna ^a   Górski, Paweł ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

2011 GOLD report; CAT questionnaire; Category ABCD; COPD; Spirometry

Indexed keywords

AGED; CLASSIFICATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SMOKING; SPIROMETRY;

AGED; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SMOKING; SPIROMETRY;

EID: 84906324551     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: 10.5603/PiAP.2014.0054     Document Type: Article

References (41)

1. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PloS Med. 2006; 3: e442
2. Rabe K.F., Hurd S., Anzueto A. et al. and the Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007; 176: 532-555
3. Soriano J.B., Visick G.T., Muellerova H. et al. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005; 128: 2099-2107
4. Mannino D.M., Thorn D., Swensen A., Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur. Respir. J. 2008; 32: 962-969
5. Curkendall S.M., Lanes S., de Luise C. et al. Chronic obstructive pulmonary disease severity and cardiovascular outcomes. Eur. J. Epidemiol. 2006; 21: 803-813
6. Agusti A., Calverley P.M., Celli B. et al. and the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir. Res. 2010; 11: 122-136
7. Calverley P.M., Anderson J.A., Celli B. et al. TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 2007; 356: 775-789
8. Tashkin D.P., Celli B., Senn S. et al. Uplift Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 2008; 359: 1543-1554
9. Vestbo J., Hurd S.S., Agusti A.G. et al. Global Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. GOLD Executive Summary. Am. J. Respir. Crit. Care Med. 2013; 187: 347-365
10. Celli B.R., Cote C.G., Marin J.M. et al. The body-mass index, airfl{ligature}ow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 1005-1012
11. Puhan M.A., Garcia-Aymerich J., Frey M. et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009; 374: 704-711
12. Jones R.C., Donaldson G.C., Chavannes N.H. et al. Derivation and validation of a composite index of severity in Chronic Obstructive Pulmonary Disease The DOSE Index. Am. J. Respir. Crit. Care Med. 2009; 180: 1189-1195
13. Miller M.R., Hankinson J., Brusasco V. et al. ATS/ERS Task Force. Standardisation of spirometry. Eur. Respir. J. 2005; 26: 319-338
14. Celli B.R., MacNee W., and committee members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 2004; 23: 932-946
15. Bestall J.C., Paul E.A., Garrod R., Garnham R., Jones P.W., Wedzicha J.A. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586
16. Jones P.W., Harding G., Berry P., Wiklund I., Chen W.H., Leidy N.K. Development and first validation of the COPD Assessment Test. Eur. Respir. J. 2009; 34: 648-654
17. Jones P.W., Harding G., Wiklund I. et al. Tests of the responsiveness of the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test TM (CAT) following acute exacerbation and pulmonary rehabilitation. Chest 2012; 142: 134-140
18. Jones P.W., Brusselle G., Dal Negro R.W. et al. Properties of the COPD assessment test in a cross-sectional European study. Eur. Respir. J. 2011; 38: 29-35
19. Burge S., Wedzicha J.A. COPD exacerbations, definitions and classifications. Eur. Respir. J. 2003; 21 (suppl. 41): 46-53
20. Soriano J.B., Alfageme I., Almagro P. et al. Distribution and Prognostic Validity of the New Global Initiative for Chronic Obstructive Lung Disease Grading Classification. Chest 2013; 143: 694-702
21. Agusti A. COPD, a multicomponent disease: implication for management. Respir. Med. 2005; 99: 670-682
22. Casanova C., de Torres J.P., Aguirre-Jaime A. et al. The progression of chronic obstructive pulmonary disease is heterogenous. The experience of the BODE cohort. Am. J. Respir. Crit. Care Med. 2011; 184: 1015-1021
23. Han M.K., Muellerova H., Curran-Everett D. et al. GOLD 2011 disease severity classification in the COPD Gene study: a prospective cohort study. Lancet Respir. Med. 2012; Special Preview August 2012: 15-22
24. Hurst J.R., Vestbo J., Anzueto A. et al. and the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med. 2010; 363: 1128-1138
25. Mackay A.J., Donaldson G.C., Patel A.R., Jones P.W., Hurst J.R., Wedzicha J.A. Usefulness of the chronic obstructive pulmonary disease assessment test to evaluate severity of COPD exacerbations. Am. J. Respir. Crit. Care Med. 2012; 185: 1218-1224
26. Wedzicha J.A., Seemungal T.A.R. COPD exacerbations: defining their cause and prevention. Lancet 2007; 370: 786-796
27. Seemungal T.A.R., Donaldson G.C., Paul E.A., Bestall J.C., Jeffries D.J., Wedzicha J.A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157: 1418-1422
28. Soler-Cataluña J.J., Martinez-Garcia M.A., Roman Sanchez P., Salcedo E., Navarro M., Ochando R. Severe acute exacerbations and mortalilty in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-931
29. Suissa S., Dell'Aniello S., Ernst P. Long-term natural history of COPD: severe exacerbations and mortality. Thorax 2012; 67: 957-963
30. Fabbri L.M., Rabe K.F. From COPD to chronic systemic inflammatory syndrome? Lancet 2007; 370: 797e9
31. Wedzicha J.A. GOLD and ABCD - a good start, but now for the evidence? Lancet Respir. Med. 2012; August Special Preview: 2-3
32. Han M.K., Agusti A., Calverley P.M. et al. Chronic obstructive pulmonary disease phenotypes. The future of COPD. Am. J. Respir. Crit. Care Med. 2010; 182: 598-604
33. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013. Available from: www.goldcopd.org.
34. Soler Cataluna J.J., Martinez-Garcia M.A., Catalan Serra P. The frequent exacerbator. A new phenotype in COPD? Hot Topics Respir. Med. 2011; 19: 7-12
35. Vestbo J., Edwards L.D., Scanlon P.D. et al. Changes in forced expiratory volume in 1 second over time in COPD. N. Engl. J. Med. 2011; 365: 1184-1192
36. Agusti A., Edwards L.D., Rennard S.I. et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD a novel phenotype. PLoS One 2012; 7: e37483
37. Hardin M., Silverman E.K., Barr R.G. et al. The clinical features of the overlap between COPD and asthma. Respir. Res. 2011; 12: 127
38. Anthonisen N.R., Skeans M.A., Wise R.A., Manfreda J., Kanner R.E., Connett J.E. Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann. Intern. Med. 2005; 142: 233e9
39. de Marco R., Accordini S., Marcon A. et al. Risk factors for chronic obstructive pulmonary disease in a european cohort of young adults. Am. J. Respir. Crit. Care Med. 2011; 183: 891-897
40. de Marco R., Accordini S., Marcon A., i wsp. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am. J. Respir. Crit. Care Med. 2007; 175: 32-39
41. Cosio M.G., Saetta M., Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N. Engl. J. Med. 2009; 360: 2445-2454.